資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://irlib.pccu.edu.tw/handle/987654321/49504
|
| 題名: | MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-beta/SMAD signaling to suppress cell migration and invasion |
| 作者: | Cheng, HP (Cheng, Han Ping)
Huang, CJ (Huang, Chiu-Jung)
Tsai, ML (Tsai, Ming-Long)
Ong, HT (Ong, Hooi Tin)
Cheong, SK (Cheong, Soon Keng)
Choo, KB (Choo, Kong Bung)
Chiou, SH (Chiou, Shih-Hwa) |
| 貢獻者: | 動科系 |
| 關鍵詞: | microRNA-362
EMT/MET
SMAD4
TGF-beta/SMAD signaling pathway
cell migration/invasion
metastasis |
| 日期: | 2021 |
| 上傳時間: | 2021-04-22 11:02:33 (UTC+8) |
| 摘要: | Cell migration and invasion are modulated by epithelial-to-mesenchymal transition (EMT) and the reverse MET process. Despite the detection of microRNA-362 (miR- 362, both the miR-362-5p and -3p species) in cancers, none of the identified miR-362 targets is a mesenchymal or epithelial factor to link miR-362 with EMT/MET and metastasis. Focusing on the TGF-beta/SMAD signaling pathway in this work, luciferase assays and western blot data showed that miR-362 targeted and negatively regulated expression of SMAD4 and E-cadherin, but not SNAI1, which is regulated by SMAD4. However, miR-362 knockdown also down-regulated SMAD4 and SNAI1, but up-regulated E-cadherin expression. Wound-healing and transwell assays further showed that miR-362 knockdown suppressed cell migration and invasion, effects which were reversed by over-expressing SMAD4 or SNAI1, or by knocking down E-cadherin in the miR-362 knockdown cells. In orthotopic mice, miR-362 knockdown inhibited metastasis, and displayed the same SMAD4 and E-cadherin expression profiles in the tumors as in the in vitro studies. A scheme is proposed to integrate miR-362 negative regulation via SMAD4, and to explain miR-362 positive regulation of SMAD4 via miR-362 targeting of known SMAD4 suppressors, BRK and DACH1, which would have resulted in SMAD4 depletion and annulment of subsequent involvement in TGF-beta signaling actions. Hence, miR-362 both negatively and positively regulates SMAD4 expression in TGF-beta/SMAD signaling pathway to suppress cell motility and invasiveness and metastasis, and may explain the reported clinical association of anti-miR-362 with suppressed metastasis in various cancers. MiR-362 knockdown in miR-362-positive cancer cells may be used as a therapeutic strategy to suppress metastasis. |
| 關聯: | INTERNATIONAL JOURNAL OF MEDICAL SCIENCES 卷冊: 18 期: 8 頁數: 1798-1809 |
| 顯示於類別: | [動物科學系 ] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 218 | 檢視/開啟 |
|
在CCUR中所有的資料項目都受到原著作權保護.
|
